| Recruiting | MTS109 in Patients With Refractory Autoimmune Diseases NCT07526350 | Shanghai Changzheng Hospital | EARLY_Phase 1 |
| Not Yet Recruiting | Tongji NADs Cohort NCT07333196 | Tongji Hospital | — |
| Not Yet Recruiting | A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Idiopathic Inflamm NCT07284797 | Xencor, Inc. | Phase 1 |
| Recruiting | A Study of AZD0120 in Autoimmune Diseases NCT07295847 | AstraZeneca | Phase 1 |
| Not Yet Recruiting | EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases NCT07077304 | Assistance Publique - Hôpitaux de Paris | — |
| Not Yet Recruiting | Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV NCT06986018 | Peking University People's Hospital | EARLY_Phase 1 |
| Not Yet Recruiting | Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases NCT06970951 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | EARLY_Phase 1 |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Partic NCT06916806 | AstraZeneca | Phase 1 |
| Recruiting | Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases NCT07022197 | Tianjin Medical University General Hospital | Phase 1 / Phase 2 |
| Active Not Recruiting | A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases NCT06255028 | Century Therapeutics, Inc. | Phase 1 |
| Recruiting | Phase 2 Study of Rapcabtagene Autoleucel in Myositis NCT06665256 | Novartis Pharmaceuticals | Phase 2 |
| Recruiting | AYLo - AutoimmunitY and Loss of y NCT06696027 | University of Bonn | — |
| Enrolling By Invitation | A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease NCT06375993 | Adicet Therapeutics | Phase 1 |
| Recruiting | A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) NCT06733935 | Nkarta, Inc. | Phase 1 / Phase 2 |
| Recruiting | Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases NCT06548607 | Nanjing Bioheng Biotech Co., Ltd. | EARLY_Phase 1 |
| Suspended | Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases NCT06549296 | Nanjing Bioheng Biotech Co., Ltd. | EARLY_Phase 1 |
| Recruiting | Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body M NCT06479863 | Austin Neuromuscular Center | EARLY_Phase 1 |
| Active Not Recruiting | CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 NCT06152172 | David Porter | Phase 1 |
| Recruiting | Biomarkers in Autoimmune Disease of Nervous System NCT06502015 | Tongji Hospital | — |
| Recruiting | Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110 | Essen Biotech | Phase 1 / Phase 2 |
| Terminated | A Study of Imvotamab in Active, Refractory Idiopathic Inflammatory Myopathies NCT06524687 | IGM Biosciences, Inc. | Phase 1 |
| Not Yet Recruiting | Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases NCT06417398 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | EARLY_Phase 1 |
| Recruiting | Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases NCT06361745 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | N/A |
| Not Yet Recruiting | Clinical Study Cohort of Idiopathic Inflammatory Myositis NCT06306547 | RenJi Hospital | — |
| Recruiting | Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases NCT06285539 | UMC Utrecht | Phase 2 |
| Recruiting | Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases NCT06316076 | RenJi Hospital | Phase 1 |
| Unknown | Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopath NCT05833711 | Immunoforge Co. Ltd. | Phase 2 |
| Unknown | Characterizing Myositis With 68Ga-FAPI PET/CT NCT05952531 | The First Affiliated Hospital of Xiamen University | EARLY_Phase 1 |
| Active Not Recruiting | Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases NCT05879419 | University of Sao Paulo General Hospital | Phase 4 |
| Unknown | Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Inflammatory M NCT05400889 | Peking University People's Hospital | Phase 2 |
| Recruiting | Adult Autoimmune Myopathies (MAIA) NCT04792931 | University Hospital, Brest | N/A |
| Completed | Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular D NCT05200702 | Institut de Myologie, France | N/A |
| Completed | Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Di NCT05199246 | Institut de Myologie, France | N/A |
| Completed | JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM NCT04208464 | University of Manchester | Phase 2 |
| Recruiting | PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS NCT04664465 | University Hospital, Brest | — |
| Recruiting | Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the N NCT04561557 | Tongji Hospital | EARLY_Phase 1 |
| Unknown | Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic NCT04034199 | Kwong Wah Hospital | Phase 3 |
| Completed | Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopat NCT03918356 | Yale University | N/A |
| Unknown | Elastography in Patients With Idiopathic Inflammatory Myopathies NCT03897803 | Benha University | — |
| Completed | Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis NCT03267277 | National Institute of Environmental Health Sciences (NIEHS) | Phase 2 / Phase 3 |
| Completed | Physical Training in Patients With Idiopathic Inflammatory Myopathies NCT03092167 | University of Sao Paulo | N/A |
| Completed | Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases NCT00341679 | National Institute of Environmental Health Sciences (NIEHS) | — |
| Recruiting | Optimizing Treatment on Idiopathic Inflammatory Myopathies NCT03092180 | University of Sao Paulo | — |
| Completed | Study of Families With Twins or Siblings Discordant for Rheumatic Disorders NCT00055055 | National Institute of Environmental Health Sciences (NIEHS) | — |